Advanced Medical Solutions Grp PLC Expanded indications for LiquiBand Fix 8 (9046L)
May 01 2015 - 2:00AM
UK Regulatory
TIDMAMS
RNS Number : 9046L
Advanced Medical Solutions Grp PLC
01 May 2015
1 May 2015
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Expanded indications for LiquiBand(R) Fix 8(TM)
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L),
the surgical and advanced woundcare specialist company, today
announces that additional clinical work has been completed to allow
for expanded indications of LiquiBand(R) Fix 8(TM), the Group's
newly developed cyanoacrylate adhesive device for hernia mesh
fixation. The device is now able to be used for the laparoscopic
surgical mesh fixation for all types of abdominal hernia as well as
for the closure of the membrane lining the abdominal wall
(peritoneum).
LiquiBand(R) Fix 8(TM), an innovative device which augments
AMS's existing LiquiBand(R) range of topical tissue adhesive
products, was developed by AMS to enable the laparoscopic
attachment of hernia meshes within the body through the accurate
delivery of individual drops of cyanoacrylate adhesive. This
accurate laparoscopic application of adhesive is expected to reduce
surgical complications, in particular the potential pain associated
with the use of tacks and staples, thereby improving the patient
experience and reducing healthcare costs overall.
LiquiBand(R) Fix 8(TM) received CE approval in May 2014,
allowing the product to be used for the laparoscopic repair of
hernias occurring in the groin, which account for 75% of all
hernias. The device has been marketed and distributed by the
Group's direct sales teams in the UK and Germany and through
various distributor partners across the EU. The applications of
LiquiBand(R) Fix 8(TM) have now been extended for the laparoscopic
repair of all abdominal hernias and for the closure of the membrane
lining of the abdominal wall which may need repairing as a result
of the hernia repair procedure.
Chris Meredith, Chief Executive Officer of AMS, commented:
"LiquiBand(R) Fix 8(TM) is an important product for AMS and
demonstrates our innovation and market agility. We are delighted
with the response we have received following the launch from
surgeons who have been extremely positive about the ease of use of
this device and the benefit it brings to patients, reducing the
pain that can be experienced when tacks or staples are used. This
is the first extension of the claims of LiquiBand(R) Fix 8(TM) and
we expect to develop further opportunities for this kind of
application, broadening the market for the use of adhesives
internally. This is an important part of our strategy to increase
our penetration of the Operating Theatre segment of the wound
closure market."
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc
Chris Meredith, Chief Executive Officer
Mary Tavener, Group Finance Director +44 (0) 1606 545508
Consilium Strategic Communications +44 (0) 20 3709 5700
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Ivar Milligan AMS@consilium-comms.com
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has more approximately 470
employees. For more information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCIMMITMBBJBBA
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024